iPLEDGE: protecting patients or prohibiting access to care?
Hill
Marcia J
MJ
D000075202:Contraindications; D003879:Dermatologic Agents; D003880:Dermatology; D004345:Drug Industry / Q000458:organization & administration*; D005260:Female; D006297:Health Services Accessibility; D006801:Humans; D007373:Interinstitutional Relations; D015474:Isotretinoin; D010344:Patient Advocacy; D017410:Practice Guidelines as Topic; D011247:Pregnancy / Q000187:drug effects*; D012308:Risk Management / Q000458:organization & administration; D012956:Societies, Nursing / Q000458:organization & administration*; D013041:Specialties, Nursing / Q000458:organization & administration; D014481:United States; D014486:United States Food and Drug Administration / Q000458:organization & administration*
D003879:Dermatologic Agents; D015474:Isotretinoin